These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24727145)

  • 1. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to four Neisseria meningitidis serogroups.
    Martins TB; Jaskowski TD; Tebo A; Hill HR
    J Immunol Methods; 2009 Mar; 342(1-2):98-105. PubMed ID: 19159627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
    González E; Reyes F; Otero O; Camacho F; Cuello M; Ramírez F; Acevedo R
    Methods Mol Biol; 2019; 1969():181-203. PubMed ID: 30877678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
    Cook MC; Bliu A; Kunkel JP
    Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
    Lal G; Balmer P; Joseph H; Dawson M; Borrow R
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.
    Phugare S; Kale S; Sharma P; Kumar Goel S; Gairola S; Jadhav SS
    Vaccine; 2020 Nov; 38(49):7815-7824. PubMed ID: 33164804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
    Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
    Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.
    Beninati C; Arseni S; Mancuso G; Magliani W; Conti S; Midiri A; Biondo C; Polonelli L; Teti G
    J Immunol; 2004 Feb; 172(4):2461-8. PubMed ID: 14764718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
    Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
    Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides.
    Bårnes GK; Kristiansen PA; Caugant DA; Næss LM
    Clin Vaccine Immunol; 2015 Jul; 22(7):697-705. PubMed ID: 25924767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.